The Texas-headquartered American Heart Association, a relentless force changing the future of health for everyone, everywhere ...

The emerging public health field of food is medicine (FIM) experienced a rapid acceleration in the number of research studies ...

Please see AHA/ASA Multimedia Materials Usage Policy. I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use ...

Please see AHA/ASA Multimedia Materials Usage Policy. I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use ...

Comprehensive, individualized rehabilitation can help survivors of stroke maximize recovery, regain independence and improve quality of life, according to a new guideline from the American Stroke ...

Coordinated care among multispecialty team may reduce risk of amputation, heart attack, stroke and death for people with PAD, according to new joint guideline from the American Heart Association, the ...

While most Hispanic/Latino people in the U.S. were aware of their cardiovascular risk factors, less than half of the adults in a study of stroke survivors had healthy blood pressure and cholesterol, ...

Adults with elevated levels of three biomarkers for heart disease—lipoprotein a (also called Lp(a)), remnant cholesterol and high-sensitivity C-reactive protein (hsCRP)—had nearly triple the risk of ...

Physical activity, an essential component of any weight loss program, also supports overall heart and metabolic health, according to a new scientific statement from the American Heart Association ...

Lifestyle modification for prevention of high blood pressure and treatment for all levels of high blood pressure, early treatment of high blood pressure to reduce the risk of cognitive decline and ...

American Heart Association 2023 Statistical Update reports largest increase in the number of CVD deaths in the U.S. in years, highest among Asian, Black and Hispanic populations More people died from ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death ...